These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 15830137)
1. Expression of BP1, a novel homeobox gene, correlates with breast cancer progression and invasion. Man YG; Fu SW; Schwartz A; Pinzone JJ; Simmens SJ; Berg PE Breast Cancer Res Treat; 2005 Apr; 90(3):241-7. PubMed ID: 15830137 [TBL] [Abstract][Full Text] [Related]
2. BP1, a putative signature marker for inflammatory breast cancer and tumor aggressiveness. Man YG; Schwartz A; Levine PH; Teal C; Berg PE Cancer Biomark; 2009; 5(1):9-17. PubMed ID: 19242057 [TBL] [Abstract][Full Text] [Related]
3. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma. Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525 [TBL] [Abstract][Full Text] [Related]
4. [Clinicopathological significance of homeobox gene BP1 mRNA expression in human breast cancer]. Yu M; Yang Y; Niu RF; Shi YR; Wei XY; Zhang L; Wang DF Ai Zheng; 2004 Jul; 23(7):855-9. PubMed ID: 15248928 [TBL] [Abstract][Full Text] [Related]
5. [Expression and Significance of BP1 Gene and Cyclin D1 Gene in Breast Cancer]. Song YC; Fu SD; Wen XP; Ma ZH; Dang CX Ai Zheng; 2007 Jul; 26(7):709-14. PubMed ID: 17626745 [TBL] [Abstract][Full Text] [Related]
6. Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression. Yang C; Trent S; Ionescu-Tiba V; Lan L; Shioda T; Sgroi D; Schmidt EV Cancer Res; 2006 Dec; 66(24):11649-58. PubMed ID: 17178859 [TBL] [Abstract][Full Text] [Related]
7. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast. Hussein MR; Abd-Elwahed SR; Abdulwahed AR Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077 [TBL] [Abstract][Full Text] [Related]
8. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis. Schuetz CS; Bonin M; Clare SE; Nieselt K; Sotlar K; Walter M; Fehm T; Solomayer E; Riess O; Wallwiener D; Kurek R; Neubauer HJ Cancer Res; 2006 May; 66(10):5278-86. PubMed ID: 16707453 [TBL] [Abstract][Full Text] [Related]
9. The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types. Iacobuzio-Donahue CA; Argani P; Hempen PM; Jones J; Kern SE Cancer Res; 2002 Sep; 62(18):5351-7. PubMed ID: 12235006 [TBL] [Abstract][Full Text] [Related]
10. MnSOD expression is less frequent in tumour cells of invasive breast carcinomas than in in situ carcinomas or non-neoplastic breast epithelial cells. Soini Y; Vakkala M; Kahlos K; Pääkkö P; Kinnula V J Pathol; 2001 Sep; 195(2):156-62. PubMed ID: 11592093 [TBL] [Abstract][Full Text] [Related]
11. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer. Zhang H; Stephens LC; Kumar R Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771 [TBL] [Abstract][Full Text] [Related]
12. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone. Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090 [TBL] [Abstract][Full Text] [Related]
13. A subset of in situ breast tumor cell clusters lacks expression of proliferation and progression related markers but shows signs of stromal and vascular invasion. Man YG; Shen T; Weisz J; Berg PE; Schwartz AM; Mulshine JL; Sang QX; Nieburgs HE Cancer Detect Prev; 2005; 29(4):323-31. PubMed ID: 16122886 [TBL] [Abstract][Full Text] [Related]
14. Expression and localization of homeodomain proteins DLX4/HB9 in normal and malignant human breast tissues. Neufing PJ; Kalionis B; Horsfall DJ; Ricciardelli C; Stahl J; Vivekanandan S; Raymond W; Tilley WD Anticancer Res; 2003; 23(2B):1479-88. PubMed ID: 12820413 [TBL] [Abstract][Full Text] [Related]
15. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status. Xu Y; Yao L; Li H; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Larsson O; Xie Y Breast Cancer Res Treat; 2006 May; 97(1):49-55. PubMed ID: 16319978 [TBL] [Abstract][Full Text] [Related]
16. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R; Schaaf A Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473 [TBL] [Abstract][Full Text] [Related]
17. Breast carcinogenesis. Transition from hyperplasia to invasive lesions. Meteoglu I; Dikicioglu E; Erkus M; Culhaci N; Kacar F; Ozkara E; Uyar M Saudi Med J; 2005 Dec; 26(12):1889-96. PubMed ID: 16380768 [TBL] [Abstract][Full Text] [Related]
18. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion. Man YG; Gardner WA Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698 [TBL] [Abstract][Full Text] [Related]
19. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53]. Tang F; Gu DH; Wang H; Zhu TF; Zhu HG; Xu ZD; Hu XQ Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):192-5. PubMed ID: 16875603 [TBL] [Abstract][Full Text] [Related]
20. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma. de Candia P; Akram M; Benezra R; Brogi E Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]